| Type | Title | Author(s) | Year | Views |
| One-year follow up of melamine-associated renal stones in Sichuan and Hong Kong | Tu, WW; Yang, H; Luo, H; Shi, H; Wong, WHS; Lau, WWS; Yip, C; Yuen, SF; Chim, S; Chan, WKY; Wong, SN; Ho, CS; Feng, T; Lam, K; Li, H; Lee, PPW; Mao, M; Lau, YL | 2012 | 124 |
| |
| Microfluidic fabrication of monodisperse biocompatible and biodegradable polymersomes with controlled permeability | Ho, CS; Kim, JW; Weitz, DA | 2008 | 119 |
| |
| Development and validation of an all-cause mortality risk score in type 2 diabetes: The Hong Kong diabetes registry | Yang, X; So, WY; Tong, PCY; Ma, RCW; Kong, APS; Lam, CWK; Ho, CS; Cockram, CS; Ko, GTC; Chow, CC; Wong, VCW; Chan, JCN | 2008 | 83 |
| |
| The Enhancement of Management Education in Engineering Curricula | Ho, CS; Lee, WK; Fok, WWT | 2008 | 105 |
| |
| 1DNA-based subtyping of glycogen storage disease type III: Mutation and haplotype analysis of the AGL gene in Chinese | Lam, CW; Lee, ATC; Lam, YY; Wong, TW; Mak, TWL; Fung, WC; Chan, KC; Ho, CS; Tong, SF | 2004 | 131 |
| |
| Experimental validation of theoretical potassium and sodium cation affinities of amides by mass spectrometric kinetic method measurements | Tsang, Y; Siu, FM; Ho, CS; Ma, NL; Tsang, CW | 2004 | 86 |
| |
| Management of child abuse in Hong Kong: Results of a territory-wide interhospital prospective surveillance study | Tsang, A; Kwan, E; Yu, CM; Tai, SM; Ip, P; Cheung, P; Ho, L; Tse, W; Ho, S; But, B; Lee, WH; Cherk, SWW; Leung, LCK; Ho, CS; Tse, PWT; Chan, JYC; Cheng, PS; Wong, HL; Yau, FT; Tong, CT; Lee, KP; Yam, KL; Lee, LP; Cheng, A; Huen, KF; Mak, WC; Chan, KC; Tsui, KW; Wong, TW; Lee, ACW; Ou, Y; So, KT | 2003 | 173 |
| |
| Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration. | Chiu, RW; Ho, CS; Tong, SF; Ng, KF; Lam, CW | 2002 | 86 |
| |
| Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis | Tsang, KWT; Ho, PL; Lam, WK; Ip, MSM; Chan, KN; Ho, CS; Ooi, CCG; Yuen, KY | 1999 | 45 |
| |
| A pilot study of low-dose erythromycin in bronchiectasis | Tsang, KWT; Ho, PL; Chan, KN; Ip, MSM; Lam, WK; Ho, CS; Yuen, KY; Ooi, GC; Amitani, R; Tanaka, E | 1999 | 260 |
| |
| Low dose erthromycin in bronchiectasis | Tsang, KWT; Chan, KN; Ho, CS; Ip, MSM; Lam, WK; Lam, B; Cheung, TF; Amitani, R; Tanaka, E | 1998 | 79 |
| |
| Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis | Tsang, KWT; Ho, PL; Lam, WK; Ip, MSM; Chan, KN; Ho, CS; Ooi, CCG; Yuen, KY | 1998 | 324 |
| |
| Erythromycin reduces sputum volume and improves lung function in bronchiectasis | Tsang, KWT; Ho, PL; Ho, CS; Chan, KN; Ip, MSM; Lam, WK; Lam, B; Amitani, R; Tanaka, E | 1998 | 104 |
| |
| Ultrastructural and functional ciliary assessment in Chinese patients with bronchiectasis | Tsang, KWT; Sun, JZ; Lam, WK; Ip, MSM; Cheung, TF; Ho, CS; Lam, B; Wong, MP | 1998 | 79 |
| |
| Diffuse panbronchiolitis: the Hong Kong experience | Tsang, KWT; Lam, WK; Ooi, CGC; Lam, B; Ho, CS; Ip, MSM; Chan, KN; Amitani, R; Tanaka, E | 1998 | 228 |
| |
| Helicobacter pylori sero-prevalence is related to disease activities in bronchiectasis | Tsang, KWT; Lam, SK; Yew, WW; Ip, MSM; Ho, CS; Lam, WK | 1998 | 92 |
| |
| Anti-inflammatory effects of fluticasone in bronchiectasis | Tsang, KWT; Ho, PL; Chan, KN; Lam, WK; Ho, CS; Ip, MSM | 1998 | 187 |
| |
| Anti-inflammatory effects of inhaled fluticasone in steady state bronchiectasis | Tsang, KWT; Ho, CS; Ho, PL; Chan, KN; Lam, WK; Ip, M | 1998 | 90 |
| |
| Clinical profiles of chinese patients with diffuse panbronchiolitis | Tsang, KWT; Ooi, CGC; Ip, MSM; Lam, WK; Ngan, H; Chan, EYT; Hawkins, B; Ho, CS; Amitani, R; Tanaka, E; Itoh, H | 1998 | 238 |
| |
| Predictors of sputum microbiology in bronchiectasis | Tsang, KWT; Lam, WK; Chan, KN; Ho, PL; Ip, MSM; Ho, CS; Lam, B; Yuen, KY | 1998 | 96 |
| |
